Collegium Pharmaceutical Inc (COLL)
29.96
-0.45
(-1.48%)
USD |
NASDAQ |
Nov 22, 16:00
29.92
-0.04
(-0.13%)
Pre-Market: 20:00
Collegium Pharmaceutical Cash from Operations (Quarterly): -8.999M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.999M |
| June 30, 2024 | 67.40M |
| March 31, 2024 | 61.94M |
| December 31, 2023 | 73.34M |
| September 30, 2023 | 74.02M |
| June 30, 2023 | 99.72M |
| March 31, 2023 | 27.67M |
| December 31, 2022 | 66.32M |
| September 30, 2022 | 42.77M |
| June 30, 2022 | 40.45M |
| March 31, 2022 | -25.32M |
| December 31, 2021 | 36.20M |
| September 30, 2021 | 17.25M |
| June 30, 2021 | 29.54M |
| March 31, 2021 | 20.57M |
| December 31, 2020 | 22.58M |
| September 30, 2020 | 34.18M |
| June 30, 2020 | 43.85M |
| March 31, 2020 | -6.669M |
| December 31, 2019 | 15.66M |
| September 30, 2019 | 6.069M |
| June 30, 2019 | 14.63M |
| Date | Value |
|---|---|
| March 31, 2019 | -8.569M |
| December 31, 2018 | 42.29M |
| September 30, 2018 | 41.83M |
| June 30, 2018 | 55.60M |
| March 31, 2018 | 29.66M |
| December 31, 2017 | -13.30M |
| September 30, 2017 | -12.57M |
| June 30, 2017 | -17.47M |
| March 31, 2017 | -23.69M |
| December 31, 2016 | -23.29M |
| September 30, 2016 | -19.41M |
| June 30, 2016 | -20.84M |
| March 31, 2016 | -11.52M |
| December 31, 2015 | -8.939M |
| September 30, 2015 | -6.536M |
| June 30, 2015 | -4.411M |
| March 31, 2015 | -1.681M |
| December 31, 2014 | -7.567M |
| September 30, 2014 | -4.408M |
| June 30, 2014 | -2.201M |
| March 31, 2014 | -3.771M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.32M
Minimum
Mar 2022
99.72M
Maximum
Jun 2023
36.62M
Average
35.19M
Median
Cash from Operations (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -22.97M |
| Insmed Inc | -180.92M |
| Pulmonx Corp | -7.242M |
| RxSight Inc | 0.65M |
| Context Therapeutics Inc | -1.933M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -248.96M |
| Cash from Financing (Quarterly) | 149.03M |
| Free Cash Flow | 192.43M |
| Free Cash Flow Per Share (Quarterly) | -0.2301 |
| Free Cash Flow to Equity (Quarterly) | -323.62M |
| Free Cash Flow to Firm (Quarterly) | -0.1872M |
| Free Cash Flow Yield | 13.99% |